Simulations Plus expands FDA partnership with ADMET predictor software deal

PartnershipPositive

AI Analysis

Summary

Simulations Plus has expanded its partnership with the FDA through a new ADMET predictor software deal. The expansion strengthens the company's collaboration with regulatory authorities in drug development simulation tools.

Importance:5/10

Sentiment:

0.30

partnershipFDAsoftwareADMETexpansion

Related Companies

$SLP

Read the original article

Published by Seeking Alpha Healthcare on September 18, 2026 4:48 AM

Read Original